---
$id: https://graph.org.ai/products/commodity/51182212
$type: Product
source: UNSPSC
code: "51182212"
title: "Mepitiostane"
class: "51182200"
classTitle: "Drugs for inducing labor"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mepitiostane

**UNSPSC Code**: 51182212
**Class**: [Drugs for inducing labor](Drugs for inducing labor.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiestrogen with the molecular formula C25H40O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O00404969K, chemically known as 5-alpha-androstane, 2-alpha,3-alpha-epithio-17-beta-(1-methoxycyclopentyloxy)- but generally known as mepitiostane, which bears US NIH Compound Identifier 30605. European Medicines Agency schedules Mepitiostane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08753MIG. The term MEPITIOSTANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). MEPITIOSTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mepitiostane under HS 29372900 and SITC 54153. As of Q4 2014, MEPITIOSTANE remains the US FDA Preferred Term for this commodity. Mepitiostane bears US NLM identifiers UMLS ID C0065964 and NCI Concept Code C1158. SMILES: S1C2CC3(C4C(C5C(CC4)(C(OC4(OC)CCCC4)CC5)C)CCC3CC12)C.

